Both the autophagy markers, ATG5 and ATG 7, are known for their complex roles in other cancers (19); however, we found strong evidences supporting their pro-tumorigenic roles in CRC and targeting these genes could lead to enhanced antitumor responses (33, 36). The gene discussed is ATG5; the disease is colorectal carcinoma.